Braxia Scientific Company Description

Braxia Scientific Corp. operates as a medical research company with clinics that provide ketamine treatments for persons with depression and related disorders.

The company also owns and operates multidisciplinary clinics that offers treatment of mental health disorders.

In addition, it is involved in the research activities related to discovering and commercializing novel drugs and delivery methods; and development and acquisition of derivatives of ketamine and psilocybin, as well as other psychedelic products from its IP development platform.

The company is headquartered in Toronto, Ontario.

Braxia Scientific Corp.

Country	Canada
Industry	Biotechnology
Sector	Healthcare
CEO	Roger McIntyre

Contact Details

Address: 700 Bay Street Toronto, British Columbia M5G 1Z6 Canada
Phone	416-430-9619
Website	braxiascientific.com

Stock Details

Ticker Symbol	BRAXF
Exchange	OTCMKTS
Fiscal Year	April - March
Reporting Currency	CAD
ISIN Number	CA1057361026
SIC Code	8000

Key Executives

Name	Position
Peter Rizakos	Chief Financial Officer and Director